🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
0.3470
-0.0198 (-5.40%)
At close: Nov 19, 2026, 4:00 PM EST
0.3600
+0.0130 (3.75%)
After-hours: Nov 19, 2026, 6:41 PM EST

Neumora Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
51.7860.0962.5445.4831.1224.55
Research & Development
135.17176.07200.93142.7291.7555.78
Operating Expenses
186.94236.16263.46188.19122.8780.32
Operating Income
-186.94-236.16-263.46-188.19-122.87-80.32
Interest Expense
-7.54-3.22----
Interest & Investment Income
4.318.3419.9316.614.56-
Other Non Operating Income (Expenses)
-0.23-0.77-0.08-0.170.410.01
EBT Excluding Unusual Items
-190.4-231.8-243.61-171.75-117.9-80.31
Pretax Income
-190.4-236.8-243.61-235.66-130.9-237.31
Income Tax Expense
0.030.130.180.27--
Net Income
-190.43-236.93-243.79-235.93-130.9-237.31
Net Income to Common
-190.43-236.93-243.79-235.93-130.9-237.31
Net Income Growth
------
Shares Outstanding (Basic)
180163159652722
Shares Outstanding (Diluted)
180163159652722
Shares Change
11.70%2.52%145.12%138.99%24.25%68.46%
EPS (Basic)
-1.06-1.45-1.53-3.63-4.81-10.84
EPS (Diluted)
-1.06-1.45-1.53-3.63-4.81-10.84
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-167.31-206.44-183.71-167.99-128.41-76.24
Free Cash Flow Per Share
-0.93-1.26-1.15-2.58-4.72-3.48
EBITDA
-186.92-235.95-262.83-187.53-122.28-79.79
D&A For EBITDA
0.030.210.630.670.590.54
EBIT
-186.94-236.16-263.46-188.19-122.87-80.32
SEC Filings: 10-K · 10-Q